eosinophilic esophagitis
FDA Approves Dupixent for Pediatric Eosinophilic Esophagitis
The FDA approved Dupixent to treat eosinophilic esophagitis in children ages 1 year and older.
JANUARY 26, 2024

FDA Expands Dupilumab Indication to EoE
Dupilumab is now indicated for the treatment eosinophilic esophagitis in patients 12 years and older weighing more ...
MAY 23, 2022

Load more